Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation. A platform can help align a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment plans. Treatment plans for the treatment and management of the disease require individual development, typically including pharmacotherapy, rehabilitation interventions, regular follow-up, etc.
In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many previously difficult to treat genetic metabolic disorders have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule of disease changes. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of congenital heart defects.
The platform serves a team of internationally authoritative experts in the field of genetic metabolism at home and abroad in China. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.